Metraipolis › archive › dc_5033a784c85e

The microbiome as a therapeutic co-driver in melanoma immuno-oncology — Europe PMC PMID:41030253

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41030253
DOI
10.3389/fmed.2025.1673880
License (as archived)
solo-consultazione
Archived
2026-11-09T23:15:48.854Z
SHA-256 of the archived text
ba419758947e9168d32c9c9576a9376ebaf472351dccf30d17341cec59e6076c
Stable URL of this page
https://metraipolis.com/documento/dc_5033a784c85e

How to cite

The microbiome as a therapeutic co-driver in melanoma immuno-oncology — Europe PMC PMID:41030253 — Europe PMC (en), https://europepmc.org/article/MED/41030253 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_5033a784c85e (Metraipolis archive dc_5033a784c85e, sha256 ba419758947e9168d32c9c9576a9376ebaf472351dccf30d17341cec59e6076c)
BibTeX
@misc{dc5033a784c85e,
  title = {The microbiome as a therapeutic co-driver in melanoma immuno-oncology — Europe PMC PMID:41030253},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41030253},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_5033a784c85e; sha256 ba419758947e9168d32c9c9576a9376ebaf472351dccf30d17341cec59e6076c},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41030253. Agents can read the archived copy with the MCP tool read_document.